s6y

Genenta Science S.p.A.

Ticker
SAEN, GNTA
CIK
1838716
Industry
Biological Products, (No Diagnostic Substances)
Formerly
Genenta Science S.r.l.

Ownership 17

  1. 4 Statement of changes in beneficial ownership of securities
  2. 4 Statement of changes in beneficial ownership of securities
  3. 4 Statement of changes in beneficial ownership of securities
  4. 4 Statement of changes in beneficial ownership of securities
  5. 4 Statement of changes in beneficial ownership of securities
  6. 4 Statement of changes in beneficial ownership of securities
  7. 3 Initial statement of beneficial ownership of securities
  8. 3 Initial statement of beneficial ownership of securities
  9. 3 Initial statement of beneficial ownership of securities
  10. 3 Initial statement of beneficial ownership of securities

All 17 ownership filings

Prospectus 16

  1. 424B5 Prospectus filed pursuant to Rule 424(b)(5)
  2. 424B5 Prospectus filed pursuant to Rule 424(b)(5)
  3. 424B5 Prospectus filed pursuant to Rule 424(b)(5)
  4. 424B5 Prospectus filed pursuant to Rule 424(b)(5)
  5. 424B5 Prospectus filed pursuant to Rule 424(b)(5)
  6. S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
  7. 424B1 Prospectus filed pursuant to Rule 424(b)(1)
  8. 424B1 Prospectus filed pursuant to Rule 424(b)(1)
  9. DRSLTR Correspondence Related to Draft Registration Statement
  10. DRS/A Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy

All 16 prospectus filings

Other 86

  1. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  2. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  3. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  4. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  5. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  6. SCHEDULE 13D/A
  7. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  8. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  9. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  10. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

All 86 other filings